Sign in
4/A

Changes in Ownership

AbCellera Biologics Inc. Filed Acc 0001209191-21-068976

Options or other derivatives

  • Director acquired 91,325 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Lo Andrew Director 2021-12-03 Grant or award · Share Option (right to buy) +91,325 91,325 D
Loading xslF345X03/doc4a.xml…